JAMA Neurol:非典型性帕金森综合征特征及早期临床诊断

2019-12-25 MedSci MedSci原创

研究发现,专注于PSP-RS亚型研究很可能会遗漏大量具有潜在PSP-tau病理学的患者。脑脊液分析是区分不同CBS-AD亚型的有效手段

非典型性帕金森综合征(APS),包括进行性核上性麻痹(PSP)、皮质基底综合征(CBS)和多系统萎缩(MSA),在早期难以鉴别,常被误诊为帕金森病(PD)。近日研究人员对PSP亚型和CBS亚型特征进行了考察,评价其在APS早期诊断中的作用。

研究人员招募存在运动障碍的APS和PD的患者。APS患者分为:理查森综合征 (PSP-RS)、PSP-皮质下(包括PSP-帕金森病和进行性冻结步态亚型)、PSP-皮质(包括PSP-额叶和PSP-CBS重叠亚型)、MSA-帕金森病、小脑性MSA、CBS-阿尔茨海默病(CBS-AD)和CBS-非-AD。特征分析包含(1)临床轨迹;(2)认知筛查(3)血清神经丝轻链(NF-L)水平;(4)TRIM11、ApoE和MAPT基因型;(5)脑体积磁共振成像测量。

共222名APS患者(101名PSP患者,55名MSA患者,40名CBS患者,26名不确定患者),其中129名男性,平均年龄68.3岁,同时招募年龄匹配对照参与者(n=76)和PD患者(n=1967)。101例PSP患者中49例(48.5%)没有典型的PSP-RS亚型。与PSP-RS和PSP皮质下组相比,PSP-皮质下组的诊断潜伏期更长,临床轨迹更为良性。通过皮层容积磁共振成像(AUC,0.84-0.89),认知谱(AUC,0.80-0.83),血清NF-L水平(AUC,0.75-0.83)和TRIM11rs564309基因型,可将PSP-皮质下组与PSP-皮质和PSP-RS组区分开来。中脑萎缩是所有PSP组的共同特征。在接受脑脊液分析的17例CBS患者中,有8例(47.1%)被鉴定为CBS-AD亚型。与CBS-非-AD组相比,CBS-AD组患者有较长的诊断潜伏期、相对良性的临床轨迹、更严重的认知障碍和更高的APOE-4等位基因突变频率(AUC,0.80-0.87)。血清NF-L水平是区分PD、PSP和CBS的有效手段(AUC:0.80)。

研究发现,专注于PSP-RS亚型研究很可能会遗漏大量具有潜在PSP-tau病理学的患者。脑脊液分析是区分不同CBS-AD亚型的有效手段。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2000945, encodeId=3e5820009456b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 08 10:50:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955669, encodeId=90d4195566949, content=<a href='/topic/show?id=1e7999298d5' target=_blank style='color:#2F92EE;'>#非典型性帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99298, encryptionId=1e7999298d5, topicName=非典型性帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 22 10:50:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819167, encodeId=5333181916e94, content=<a href='/topic/show?id=556c9929e3a' target=_blank style='color:#2F92EE;'>#非典型性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99297, encryptionId=556c9929e3a, topicName=非典型性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Feb 29 15:50:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665728, encodeId=7c491665e2800, content=<a href='/topic/show?id=de2a485385f' target=_blank style='color:#2F92EE;'>#帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48538, encryptionId=de2a485385f, topicName=帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d925986347, createdName=12498f1em16(暂无昵称), createdTime=Fri Dec 27 19:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431717, encodeId=6d211431e17a1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492618, encodeId=eb281492618d8, content=<a href='/topic/show?id=9b7c9929363' target=_blank style='color:#2F92EE;'>#非典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99293, encryptionId=9b7c9929363, topicName=非典型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb98946820, createdName=sjzlzc010, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543297, encodeId=b16b154329e77, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035842, encodeId=fce51035842c6, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Dec 25 21:50:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2020-12-08 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2000945, encodeId=3e5820009456b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 08 10:50:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955669, encodeId=90d4195566949, content=<a href='/topic/show?id=1e7999298d5' target=_blank style='color:#2F92EE;'>#非典型性帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99298, encryptionId=1e7999298d5, topicName=非典型性帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 22 10:50:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819167, encodeId=5333181916e94, content=<a href='/topic/show?id=556c9929e3a' target=_blank style='color:#2F92EE;'>#非典型性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99297, encryptionId=556c9929e3a, topicName=非典型性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Feb 29 15:50:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665728, encodeId=7c491665e2800, content=<a href='/topic/show?id=de2a485385f' target=_blank style='color:#2F92EE;'>#帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48538, encryptionId=de2a485385f, topicName=帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d925986347, createdName=12498f1em16(暂无昵称), createdTime=Fri Dec 27 19:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431717, encodeId=6d211431e17a1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492618, encodeId=eb281492618d8, content=<a href='/topic/show?id=9b7c9929363' target=_blank style='color:#2F92EE;'>#非典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99293, encryptionId=9b7c9929363, topicName=非典型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb98946820, createdName=sjzlzc010, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543297, encodeId=b16b154329e77, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035842, encodeId=fce51035842c6, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Dec 25 21:50:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2000945, encodeId=3e5820009456b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 08 10:50:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955669, encodeId=90d4195566949, content=<a href='/topic/show?id=1e7999298d5' target=_blank style='color:#2F92EE;'>#非典型性帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99298, encryptionId=1e7999298d5, topicName=非典型性帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 22 10:50:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819167, encodeId=5333181916e94, content=<a href='/topic/show?id=556c9929e3a' target=_blank style='color:#2F92EE;'>#非典型性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99297, encryptionId=556c9929e3a, topicName=非典型性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Feb 29 15:50:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665728, encodeId=7c491665e2800, content=<a href='/topic/show?id=de2a485385f' target=_blank style='color:#2F92EE;'>#帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48538, encryptionId=de2a485385f, topicName=帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d925986347, createdName=12498f1em16(暂无昵称), createdTime=Fri Dec 27 19:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431717, encodeId=6d211431e17a1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492618, encodeId=eb281492618d8, content=<a href='/topic/show?id=9b7c9929363' target=_blank style='color:#2F92EE;'>#非典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99293, encryptionId=9b7c9929363, topicName=非典型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb98946820, createdName=sjzlzc010, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543297, encodeId=b16b154329e77, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035842, encodeId=fce51035842c6, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Dec 25 21:50:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2000945, encodeId=3e5820009456b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 08 10:50:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955669, encodeId=90d4195566949, content=<a href='/topic/show?id=1e7999298d5' target=_blank style='color:#2F92EE;'>#非典型性帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99298, encryptionId=1e7999298d5, topicName=非典型性帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 22 10:50:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819167, encodeId=5333181916e94, content=<a href='/topic/show?id=556c9929e3a' target=_blank style='color:#2F92EE;'>#非典型性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99297, encryptionId=556c9929e3a, topicName=非典型性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Feb 29 15:50:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665728, encodeId=7c491665e2800, content=<a href='/topic/show?id=de2a485385f' target=_blank style='color:#2F92EE;'>#帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48538, encryptionId=de2a485385f, topicName=帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d925986347, createdName=12498f1em16(暂无昵称), createdTime=Fri Dec 27 19:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431717, encodeId=6d211431e17a1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492618, encodeId=eb281492618d8, content=<a href='/topic/show?id=9b7c9929363' target=_blank style='color:#2F92EE;'>#非典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99293, encryptionId=9b7c9929363, topicName=非典型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb98946820, createdName=sjzlzc010, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543297, encodeId=b16b154329e77, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035842, encodeId=fce51035842c6, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Dec 25 21:50:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2000945, encodeId=3e5820009456b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 08 10:50:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955669, encodeId=90d4195566949, content=<a href='/topic/show?id=1e7999298d5' target=_blank style='color:#2F92EE;'>#非典型性帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99298, encryptionId=1e7999298d5, topicName=非典型性帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 22 10:50:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819167, encodeId=5333181916e94, content=<a href='/topic/show?id=556c9929e3a' target=_blank style='color:#2F92EE;'>#非典型性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99297, encryptionId=556c9929e3a, topicName=非典型性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Feb 29 15:50:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665728, encodeId=7c491665e2800, content=<a href='/topic/show?id=de2a485385f' target=_blank style='color:#2F92EE;'>#帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48538, encryptionId=de2a485385f, topicName=帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d925986347, createdName=12498f1em16(暂无昵称), createdTime=Fri Dec 27 19:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431717, encodeId=6d211431e17a1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492618, encodeId=eb281492618d8, content=<a href='/topic/show?id=9b7c9929363' target=_blank style='color:#2F92EE;'>#非典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99293, encryptionId=9b7c9929363, topicName=非典型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb98946820, createdName=sjzlzc010, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543297, encodeId=b16b154329e77, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035842, encodeId=fce51035842c6, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Dec 25 21:50:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2000945, encodeId=3e5820009456b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 08 10:50:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955669, encodeId=90d4195566949, content=<a href='/topic/show?id=1e7999298d5' target=_blank style='color:#2F92EE;'>#非典型性帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99298, encryptionId=1e7999298d5, topicName=非典型性帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 22 10:50:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819167, encodeId=5333181916e94, content=<a href='/topic/show?id=556c9929e3a' target=_blank style='color:#2F92EE;'>#非典型性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99297, encryptionId=556c9929e3a, topicName=非典型性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Feb 29 15:50:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665728, encodeId=7c491665e2800, content=<a href='/topic/show?id=de2a485385f' target=_blank style='color:#2F92EE;'>#帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48538, encryptionId=de2a485385f, topicName=帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d925986347, createdName=12498f1em16(暂无昵称), createdTime=Fri Dec 27 19:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431717, encodeId=6d211431e17a1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492618, encodeId=eb281492618d8, content=<a href='/topic/show?id=9b7c9929363' target=_blank style='color:#2F92EE;'>#非典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99293, encryptionId=9b7c9929363, topicName=非典型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb98946820, createdName=sjzlzc010, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543297, encodeId=b16b154329e77, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035842, encodeId=fce51035842c6, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Dec 25 21:50:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2000945, encodeId=3e5820009456b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 08 10:50:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955669, encodeId=90d4195566949, content=<a href='/topic/show?id=1e7999298d5' target=_blank style='color:#2F92EE;'>#非典型性帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99298, encryptionId=1e7999298d5, topicName=非典型性帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 22 10:50:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819167, encodeId=5333181916e94, content=<a href='/topic/show?id=556c9929e3a' target=_blank style='color:#2F92EE;'>#非典型性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99297, encryptionId=556c9929e3a, topicName=非典型性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Feb 29 15:50:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665728, encodeId=7c491665e2800, content=<a href='/topic/show?id=de2a485385f' target=_blank style='color:#2F92EE;'>#帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48538, encryptionId=de2a485385f, topicName=帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d925986347, createdName=12498f1em16(暂无昵称), createdTime=Fri Dec 27 19:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431717, encodeId=6d211431e17a1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492618, encodeId=eb281492618d8, content=<a href='/topic/show?id=9b7c9929363' target=_blank style='color:#2F92EE;'>#非典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99293, encryptionId=9b7c9929363, topicName=非典型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb98946820, createdName=sjzlzc010, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543297, encodeId=b16b154329e77, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035842, encodeId=fce51035842c6, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Dec 25 21:50:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2000945, encodeId=3e5820009456b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 08 10:50:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955669, encodeId=90d4195566949, content=<a href='/topic/show?id=1e7999298d5' target=_blank style='color:#2F92EE;'>#非典型性帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99298, encryptionId=1e7999298d5, topicName=非典型性帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Mon Jun 22 10:50:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819167, encodeId=5333181916e94, content=<a href='/topic/show?id=556c9929e3a' target=_blank style='color:#2F92EE;'>#非典型性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99297, encryptionId=556c9929e3a, topicName=非典型性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sat Feb 29 15:50:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665728, encodeId=7c491665e2800, content=<a href='/topic/show?id=de2a485385f' target=_blank style='color:#2F92EE;'>#帕金森综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48538, encryptionId=de2a485385f, topicName=帕金森综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d925986347, createdName=12498f1em16(暂无昵称), createdTime=Fri Dec 27 19:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431717, encodeId=6d211431e17a1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492618, encodeId=eb281492618d8, content=<a href='/topic/show?id=9b7c9929363' target=_blank style='color:#2F92EE;'>#非典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99293, encryptionId=9b7c9929363, topicName=非典型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb98946820, createdName=sjzlzc010, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543297, encodeId=b16b154329e77, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Fri Dec 27 09:50:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035842, encodeId=fce51035842c6, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Dec 25 21:50:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-25 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0